The Presence of Telomere Fusion in Sporadic Colon Cancer Independently of Disease Stage, TP53/KRAS Mutation Status, Mean Telomere Length, and Telomerase Activity

Neoplasia (United States)

Volumn 16, Issue 10, 2014, Pages 814-823

  Tanaka, Hiromi ^a   Beam, Matthew J ^a   Caruana, Kevin ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KRAS PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN P53; RAS PROTEIN; TELOMERASE; TP53 PROTEIN, HUMAN;

AGED; COLON TUMOR; FEMALE; GENETICS; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; MUTATION; PATHOLOGY; TELOMERE; TELOMERE SHORTENING; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MUTATION; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; TELOMERASE; TELOMERE; TELOMERE SHORTENING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84934287509     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1016/j.neo.2014.08.009     Document Type: Article

References (83)

1. Blackburn E.H. Switching and signaling at the telomere. Cell 2001, 106:661-673. [Review].
2. Moyzis R.K., Buckingham J.M., Cram L.S., Dani M., Deaven L.L., Jones M.D., Meyne J., Ratliff R.L., Wu J.R. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci U S A 1988, 85:6622-6626.
3. DePinho R.A. The age of cancer. Nature 2000, 408:248-254. [Review].
4. Feldser D.M., Hackett J.A., Greider C.W. Telomere dysfunction and the initiation of genome instability. Nat Rev Cancer 2003, 3:623-627.
5. Hackett J.A., Feldser D.M., Greider C.W. Telomere dysfunction increases mutation rate and genomic instability. Cell 2001, 106:275-286.
6. Murnane J.P. Telomere loss as a mechanism for chromosome instability in human cancer. Cancer Res 2010, 70:4255-4259. [Review].
7. Murnane J.P. Telomere dysfunction and chromosome instability. Mutat Res 2012, 730:28-36. [Review].
8. Capper R., Britt-Compton B., Tankimanova M., Rowson J., Letsolo B., Man S., Haughton M., Baird D.M. The nature of telomere fusion and a definition of the critical telomere length in human cells. Genes Dev 2007, 21:2495-2508.
9. Decottignies A., d'Adda di Fagagna F. Epigenetic alterations associated with cellular senescence: a barrier against tumorigenesis or a red carpet for cancer?. Semin Cancer Biol 2011, 21:360-366. [Review].
10. Hayashi M.T., Cesare A.J., Fitzpatrick J.A., Lazzerini-Denchi E., Karlseder J. A telomere-dependent DNA damage checkpoint induced by prolonged mitotic arrest. Nat Struct Mol Biol 2012, 19:387-394.
11. Suram A., Kaplunov J., Patel P.L., Ruan H., Cerutti A., Boccardi V., Fumagalli M., Di Micco R., Mirani N., Gurung R.L., et al. Oncogene-induced telomere dysfunction enforces cellular senescence in human cancer precursor lesions. EMBO J 2012, 31:2839-2851.
12. van Steensel B., Smogorzewska A., de Lange T. TRF2 protects human telomeres from end-to-end fusions. Cell 1998, 92:401-413.
13. Vera E., Canela A., Fraga M.F., Esteller M., Blasco M.A. Epigenetic regulation of telomeres in human cancer. Oncogene 2008, 27:6817-6833.
14. Greider C.W., Blackburn E.H. The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell 1987, 51:887-898.
15. Cech T.R. Beginning to understand the end of the chromosome. Cell 2004, 116:273-279. [Review].
16. Kim N.W., Piatyszek M.A., Prowse K.R., Harley C.B., West M.D., Ho P.L., Coviello G.M., Wright W.E., Weinrich S.L., Shay J.W. Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266:2011-2015.
17. Nakayama J., Tahara H., Tahara E., Saito M., Ito K., Nakamura H., Nakanishi T., Tahara E., Ide T., Ishikawa F. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet 1998, 18:65-68.
18. Tanaka H., Shimizu M., Horikawa I., Kugoh H., Yokota J., Barrett J.C., Oshimura M. Evidence for a putative telomerase repressor gene in the 3p14.2-p21.1 region. Genes Chromosomes Cancer 1998, 23:123-133.
19. Hahn W.C., Counter C.M., Lundberg A.S., Beijersbergen R.L., Brooks M.W., Weinberg R.A. Creation of human tumour cells with defined genetic elements. Nature 1999, 400:464-468.
20. Artandi S.E., Chang S., Lee S.L., Alson S., Gottlieb G.J., Chin L., DePinho R.A. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 2000, 406:641-645.
21. O'Hagan R.C., Chang S., Maser R.S., Mohan R., Artandi S.E., Chin L., DePinho R.A. Telomere dysfunction provokes regional amplification and deletion in cancer genomes. Cancer Cell 2002, 2:149-155.
22. Cosme-Blanco W., Shen M.F., Lazar A.J., Pathak S., Lozano G., Multani A.S., Chang S. Telomere dysfunction suppresses spontaneous tumorigenesis in vivo by initiating p53-dependent cellular senescence. EMBO Rep 2007, 8:497-503.
23. Begus-Nahrmann Y., Hartmann D., Kraus J., Eshraghi P., Scheffold A., Grieb M., Rasche V., Schirmacher P., Lee H.W., Kestler H.A., et al. Transient telomere dysfunction induces chromosomal instability and promotes carcinogenesis. J Clin Invest 2012, 122:2283-2288.
24. Ding Z., Wu C.J., Jaskelioff M., Ivanova E., Kost-Alimova M., Protopopov A., Chu G.C., Wang G., Lu X., Labrot E.S., et al. Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastases. Cell 2012, 148:896-907.
25. Calado R.T., Dumitriu B. Telomere dynamics in mice and humans. Semin Hematol 2013, 50:165-174. [Review].
26. Smogorzewska A., de Lange T. Different telomere damage signaling pathways in human and mouse cells. EMBO J 2002, 21:4338-4348.
27. Wright W.E., Shay J.W. Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology. Nat Med 2000, 6:849-851. [Review].
28. Beauséjour C.M., Krtolica A., Galimi F., Narita M., Lowe S.W., Yaswen P., Campisi J. Reversal of human cellular senescence: roles of the p53 and p16 pathways. EMBO J 2003, 22:4212-4222.
29. Itahana K., Campisi J., Dimri G.P. Mechanisms of cellular senescence in human and mouse cells. Biogerontology 2004, 5:1-10. [Review].
30. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990, 61:759-767.
31. Blount P.L., Galipeau P.C., Sanchez C.A., Neshat K., Levine D.S., Yin J., Suzuki H., Abraham J.M., Meltzer S.J., Reid B.J. 17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy. Cancer Res 1994, 54:2292-2295.
32. Carder P., Wyllie A.H., Purdie C.A., Morris R.G., White S., Piris J., Bird C.C. Stabilised p53 facilitates aneuploid clonal divergence in colorectal cancer. Oncogene 1993, 8:1397-1401.
33. Leslie A., Pratt N.R., Gillespie K., Sales M., Kernohan N.M., Smith G., Wolf C.R., Carey F.A., Steele R.J. Mutations of APC, K-ras, and p53 are associated with specific chromosomal aberrations in colorectal adenocarcinomas. Cancer Res 2003, 63:4656-4661.
34. Weisenberger D.J., Siegmund K.D., Campan M., Young J., Long T.I., Faasse M.A., Kang G.H., Widschwendter M., Weener D., Buchanan D., et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006, 38:787-793.
35. Engelhardt M., Drullinsky P., Guillem J., Moore M.A. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Clin Cancer Res 1997, 3:1931-1941.
36. Plentz R.R., Wiemann S.U., Flemming P., Meier P.N., Kubicka S., Kreipe H., Manns M.P., Rudolph K.L. Telomere shortening of epithelial cells characterises the adenoma-carcinoma transition of human colorectal cancer. Gut 2003, 52:1304-1307.
37. Rampazzo E., Bertorelle R., Serra L., Terrin L., Candiotto C., Pucciarelli S., Del Bianco P., Nitti D., De Rossi A. Relationship between telomere shortening, genetic instability, and site of tumour origin in colorectal cancers. Br J Cancer 2010, 102:1300-1305.
38. Roger L., Jones R.E., Heppel N.H., Williams G.T., Sampson J.R., Baird D.M. Extensive telomere erosion in the initiation of colorectal adenomas and its association with chromosomal instability. J Natl Cancer Inst 2013, 105:1202-1211.
39. Bailey S.M., Meyne J., Chen D.J., Kurimasa A., Li G.C., Lehnert B.E., Goodwin E.H. DNA double-strand break repair proteins are required to cap the ends of mammalian chromosomes. Proc Natl Acad Sci U S A 1999, 96:14899-14904.
40. Cesare A.J., Hayashi M.T., Crabbe L., Karlseder J. The telomere deprotection response is functionally distinct from the genomic DNA damage response. Mol Cell 2013, 51:141-155.
41. Gilley D., Tanaka H., Hande M.P., Kurimasa A., Li G.C., Oshimura M., Chen D.J. DNA-PKcs is critical for telomere capping. Proc Natl Acad Sci U S A 2001, 98:15084-15088.
42. Iwano T., Tachibana M., Reth M., Shinkai Y. Importance of TRF1 for functional telomere structure. J Biol Chem 2004, 279:1442-1448.
43. Nakamura M., Nabetani A., Mizuno T., Hanaoka F., Ishikawa F. Alterations of DNA and chromatin structures at telomeres and genetic instability in mouse cells defective in DNA polymerase alpha. Mol Cell Biol 2005, 25:11073-11088.
44. Saltman D., Morgan R., Cleary M.L., de Lange T. Telomeric structure in cells with chromosome end associations. Chromosoma 1993, 102:121-128.
45. Samper E., Goytisolo F.A., Slijepcevic P., van Buul P.P., Blasco M.A. Mammalian Ku86 protein prevents telomeric fusions independently of the length of TTAGGG repeats and the G-strand overhang. EMBO Rep 2000, 1:244-252.
46. Zou Y., Sfeir A., Gryaznov S.M., Shay J.W., Wright W.E. Does a sentinel or a subset of short telomeres determine replicative senescence?. Mol Biol Cell 2004, 15:3709-3718.
47. Rudolph K.L., Millard M., Bosenberg M.W., DePinho R.A. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat Genet 2001, 28:155-159.
48. Hauf S., Waizenegger I.C., Peters J.M. Cohesin cleavage by separase required for anaphase and cytokinesis in human cells. Science 2001, 293:1320-1323.
49. Acilan C., Potter D.M., Saunders W.S. DNA repair pathways involved in anaphase bridge formation. Genes Chromosomes Cancer 2007, 46:522-531.
50. Tanaka H., Abe S., Huda N., Tu L., Beam M.J., Grimes B., Gilley D. Telomere fusions in early human breast carcinoma. Proc Natl Acad Sci U S A 2012, 109:14098-14103.
51. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215.
52. Cawthon R.M. Telomere measurement by quantitative PCR. Nucleic Acids Res 2002, 30(10):e47.
53. Cawthon R.M. Telomere length measurement by a novel monochrome multiplex quantitative PCR method. Nucleic Acids Res 2009, 37:e21.
54. Herbert B.S., Hochreiter A.E., Wright W.E., Shay J.W. Nonradioactive detection of telomerase activity using the telomeric repeat amplification protocol. Nat Protoc 2006, 1:1583-1590.
55. Wright W.E., Shay J.W., Piatyszek M.A. Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivity. Nucleic Acids Res 1995, 23:3794-3795.
56. Brown W.R., MacKinnon P.J., Villasanté A., Spurr N., Buckle V.J., Dobson M.J. Structure and polymorphism of human telomere-associated DNA. Cell 1990, 63:119-132.
57. IJdo J.W., Baldini A., Ward D.C., Reeders S.T., Wells R.A. Origin of human chromosome 2: an ancestral telomere-telomere fusion. Proc Natl Acad Sci U S A 1991, 88:9051-9055.
58. Letsolo B.T., Rowson J., Baird D.M. Fusion of short telomeres in human cells is characterized by extensive deletion and microhomology, and can result in complex rearrangements. Nucleic Acids Res 2010, 38:1841-1852.
59. Celebiler Cavusoglu A., Sevinc A.I., Saydam S., Canda T., Baskan Z., Kilic Y., Sakizli M. Promoter methylation and expression changes of CDH1 and P16 genes in invasive breast cancer and adjacent normal breast tissue. Neoplasma 2010, 57(5):465-472.
60. Chandran U.R., Dhir R., Ma C., Michalopoulos G., Becich M., Gilbertson J. Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors. BMC Cancer 2005, 5:45.
61. Försti A., Louhelainen J., Söderberg M., Wijkström H., Hemminki K. Loss of heterozygosity in tumour-adjacent normal tissue of breast and bladder cancer. Eur J Cancer 2001, 37(11):1372-1380.
62. Schmitt C.A., Thaler K.R., Wittig B.M., Kaulen H., Meyer zum Büschenfelde K.H., Dippold W.G. Detection of the DCC gene product in normal and malignant colorectal tissues and its relation to a codon 201 mutation. Br J Cancer 1998, 77:588-594.
63. Zhu D., Keohavong P., Finkelstein S.D., Swalsky P., Bakker A., Weissfeld J., Srivastava S., Whiteside T.L. K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients. Cancer Res 1997, 57:2485-2492.
64. Frankfurt O.S., Slocum H.K., Rustum Y.M., Arbuck S.G., Pavelic Z.P., Petrelli N., Huben R.P., Pontes E.J., Greco W.R. Flow cytometric analysis of DNA aneuploidy in primary and metastatic human solid tumors. Cytometry 1984, 5(1):71-80.
65. Kearney T.J., Price E.A., Lee S., Silberman A.W. Tumor aneuploidy in young patients with colorectal cancer. Cancer 1993, 72(1):42-45.
66. Solomon E. Molecular genetics. Colorectal cancer genes. Nature 1990, 343:412-414.
67. Ngoi S.S., Staiano-Coico L., Godwin T.A., Wong R.J., DeCosse J.J. Abnormal DNA ploidy and proliferative patterns in superficial colonic epithelium adjacent to colorectal cancer. Cancer 1990, 66(5):953-959.
68. Saccani Jotti G., Fontanesi M., Orsi N., Sarli L., Pietra N., Peracchia A., Sansebastiano G., Becchi G. DNA content in human colon cancer and non-neoplastic adjacent mucosa. Int J Biol Markers 1995, 10(1):11-16.
69. Heaphy C.M., Meeker A.K. The potential utility of telomere-related markers for cancer diagnosis. J Cell Mol Med 2011, 15:1227-1238. [Review].
70. Lin T.T., Letsolo B.T., Jones R.E., Rowson J., Pratt G., Hewamana S., Fegan C., Pepper C., Baird D.M. Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisis. Blood 2010, 116:1899-1907.
71. Martinez-Delgado B., Gallardo M., Tanic M., Yanowsky K., Inglada-Perez L., Barroso A., Rodriguez-Pinilla M., Cañamero M., Blasco M.A., Benitez J. Short telomeres are frequent in hereditary breast tumors and are associated with high tumor grade. Breast Cancer Res Treat 2013, 141:231-242.
72. Valls C., Piñol C., Reñé J.M., Buenestado J., Viñas J. Telomere length is a prognostic factor for overall survival in colorectal cancer. Colorectal Dis 2011, 13:1265-1272.
73. Carter S.L., Cibulskis K., Helman E., McKenna A., Shen H., Zack T., Laird P.W., Onofrio R.C., Winckler W., Weir B.A., et al. Absolute quantification of somatic DNA alterations in human cancer. Nat Biotechnol 2012, 30:413-421.
74. Diker-Cohen T., Uziel O., Szyper-Kravitz M., Shapira H., Natur A., Lahav M. The effect of chemotherapy on telomere dynamics: clinical results and possible mechanisms. Leuk Lymphoma 2013, 54:2023-2029.
75. Martinez-Delgado B., Yanowsky K., Inglada-Perez L., Domingo S., Urioste M., Osorio A., Benitez J. Genetic anticipation is associated with telomere shortening in hereditary breast cancer. PLoS Genet 2011, 7:e1002182.
76. Schröder C.P., Wisman G.B., de Jong S., van der Graaf W.T., Ruiters M.H., Mulder N.H., de Leij L.F., van der Zee A.G., de Vries E.G. Telomere length in breast cancer patients before and after chemotherapy with or without stem cell transplantation. Br J Cancer 2001, 84:1348-1353.
77. Unryn B.M., Hao D., Glück S., Riabowol K.T. Acceleration of telomere loss by chemotherapy is greater in older patients with locally advanced head and neck cancer. Clin Cancer Res 2006, 12:6345-6350.
78. Allsopp R.C., Chang E., Kashefi-Aazam M., Rogaev E.I., Piatyszek M.A., Shay J.W., Harley C.B. Telomere shortening is associated with cell division in vitro and in vivo. Exp Cell Res 1995, 220:194-200.
79. Hastie N.D., Dempster M., Dunlop M.G., Thompson A.M., Green D.K., Allshire R.C. Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990, 346:866-868.
80. Bachor C., Bachor O.A., Boukamp P. Telomerase is active in normal gastrointestinal mucosa and not up-regulated in precancerous lesions. J Cancer Res Clin Oncol 1999, 125:453-460.
81. Ghori A., Usselmann B., Ferryman S., Morris A., Fraser I. Telomerase expression of malignant epithelial cells correlates with Dukes' stage in colorectal cancer. Colorectal Dis 2002, 4:441-446.
82. Liu J.L., Ge L.Y., Zhang G.N. Telomerase activity and human telomerase reverse transcriptase expression in colorectal carcinoma. World J Gastroenterol 2006, 12:465-467.
83. Tahara H., Kuniyasu H., Yokozaki H., Yasui W., Shay J.W., Ide T., Tahara E. Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions. Clin Cancer Res 1995, 1:1245-1251.